Skip to Navigation Skip to Search Skip to Content
Search All Centers

ASH 2020 MPN Daily Wrap-Up: New Research and Early Detection

Published on December 10, 2020

Experts Discuss the Latest Discoveries in MPN Detection, Treatment and Care

In this live conversation, myeloproliferative neoplasm (MPN) experts Dr. Naveen Pemmaraju of MD Anderson Cancer Center in Houston, Texas and Dr. Michael Mauro of Memorial Sloan Kettering Cancer Center in New York City discussed promising new treatment options being presented at ASH 2020, the American Society of Hematology Annual Meeting & Exposition, with Patient Power co-founders Andrew and Esther Schorr. The panel also shared thoughts on advances in early detection, effective drug combinations, emerging research and the decisions facing patients and their loved ones regarding COVID-19 and the holidays.

This series is sponsored by Bristol Myers Squibb. This organization has no editorial control. It is produced by Patient Power, and Patient Power is solely responsible for program content.

Recommended for You: